Investing in ASX biotech ft. Dr Megan Baldwin & Jeremy Curnock Cook

Jeremy Curnock Cook of BioScience Managers and Dr Megan Baldwin of Opthea Ltd (ASX: OPT) join Owen Rask on The Australian Investors Podcast.

Listen now

About this episode

Jeremy Curnock Cook is the Managing Director and founder of BioScience Managers, a funds management business specialising in biotechnology investments in Australia and globally. He is also a director of Avita Medical Inc (ASX: AVH). Jeremy joins Owen Rask on The Australian Investors Podcast, alongside Dr Megan Baldwin of Opthea Ltd (ASX: OPT).

Dr Baldwin is one of Australia’s most experienced biotechnology CEOs and holds a PhD in Medicine. Together, Owen, Megan and Jeremy dive deep into what’s included in clinical trials, investing in early, mid and late-stage biotechnology and more.

Opthea & Avita Medical share price 

Episode resources

Podcast series resources

If you like this episode, you’ll LOVE our series. Episodes go live every Saturday at 7 am and Wednesday arvo.

We air an interview with an Australian or international investing expert every Wednesday, and Q&A every Saturday! Subscribe below.

Got a question you want answered on the podcast?

Sponsored by:

Share this episode:

Facebook
X
LinkedIn
Email
WhatsApp

Better investing starts here.

Want to level-up your analytical skills and investing insights but don’t know where to start? Join 50,000 Australian investors on our mailing list and we’ll send you our favourite podcasts, courses, resources and investment articles every Sunday morning. Grab a coffee and let Owen and the team bring you the best  insights.

Skip to content